BALTIMORE, June 29, 2010 (GLOBE NEWSWIRE) -- Goldman Small Cap Research, a stock market research firm focused on the smallcap and micro cap sectors, has released today an analysis of Hythiam's (OTCBB:HYTM) landmark announcement. Hythiam is a provider of specialized behavioral health management services, specifically substance dependence programs, to health plans, employers and unions.
In the Goldman Opportunity Research update on the Company, Rob Goldman provides detailed analysis of today's announcement. "We believe this agreement could ultimately be worth $10 million to Hythiam. In addition this should be viewed as a catalyst for larger contracts for the Company in Q3."
To view a summary of the report or download the report in its entirety, please visit www.goldmanresearch.com.
About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces small cap stock market research reports and weekly newsletters. For more information, visit www.goldmanresearch.com.
A Goldman Small Cap Research report is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read the report's full disclosures and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer. To download our research or for more information, visit www.goldmanresearch.com.
About Hythiam, Inc.: Hythiam, Inc. (OTCBB:HYTM) is a healthcare services management pioneer, provides specialized behavioral health management services for substance abuse, through its Catasys subsidiary. These services are offered to health plans, employers and unions through a network of licensed and company managed healthcare providers. The Catasys substance dependence program is designed to address substance dependence as a chronic disease. The program seeks to lower costs and improve member health through the delivery of integrated medical and psychosocial interventions in combination with long term care coaching, including the proprietary PROMETA(R) Treatment Program for alcoholism and stimulant dependence.